Typical and Atypical Inducers of Lysosomal Cell Death: A Promising Anticancer Strategy
Open Access
- 1 August 2018
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 19 (8) , 2256
Abstract
Lysosomes are conservative organelles with an indispensable role in cellular degradation and the recycling of macromolecules. However, in light of recent findings, it has emerged that the role of lysosomes in cancer cells extends far beyond cellular catabolism and includes a variety of cellular pathways, such as proliferation, metastatic potential, and drug resistance. It has been well described that malignant transformation leads to alterations in lysosomal structure and function, which, paradoxically, renders cancer cells more sensitive to lysosomal destabilization. Furthermore, lysosomes are implicated in the regulation and execution of cell death in response to diverse stimuli and it has been shown that lysosome-dependent cell death can be utilized to overcome apoptosis and drug resistance. Thus, the purpose of this review is to characterize the role of lysosome in cancer therapy and to describe how these organelles impact treatment resistance. We summarized the characteristics of typical inducers of lysosomal cell death, which exert its function primarily via alterations in the lysosomal compartment. The review also presents other anticancer agents with the predominant mechanism of action different from lysosomal destabilization, the activity of which is influenced by lysosomal signaling, including classical chemotherapeutics, kinase inhibitors, monoclonal antibodies, as well as photodynamic therapy.Keywords
Funding Information
- Narodowe Centrum Nauki (2016/21/B/NZ7/02041)
- Horizon 2020 Framework Programme (692180-STREAMH2020-TWINN-2015)
This publication has 110 references indexed in Scilit:
- Synergistic apoptotic response between valproic acid and fludarabine in chronic lymphocytic leukaemia (CLL) cells involves the lysosomal protease cathepsin BBlood Cancer Journal, 2013
- Siramesine triggers cell death through destabilisation of mitochondria, but not lysosomesCell Death & Disease, 2013
- HSP70 inhibition by 2-phenylethynesulfonamide induces lysosomal cathepsin D release and immunogenic cell death in primary effusion lymphomaCell Death & Disease, 2013
- Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiencyProceedings of the National Academy of Sciences, 2012
- Antileukemic activity of the HSP70 inhibitor pifithrin-μ in acute leukemiaBlood Cancer Journal, 2011
- A Novel Sphingosine Kinase Inhibitor Induces Autophagy in Tumor CellsThe Journal of Pharmacology and Experimental Therapeutics, 2010
- Hsp70 stabilizes lysosomes and reverts Niemann–Pick disease-associated lysosomal pathologyNature, 2010
- ABC transporters: the power to changeNature Reviews Molecular Cell Biology, 2009
- Autophagy fights disease through cellular self-digestionNature, 2008
- Lysosomes in iron metabolism, ageing and apoptosisHistochemistry and Cell Biology, 2008